Drug discovery and resistancemicrococcin (cas 1392-45-6) P1 – A bactericidal thiopeptide active against Mycobacterium tuberculosis
-
Add time:09/02/2019 Source:sciencedirect.com
SummaryThe lack of proper treatment for serious infectious diseases due to the emergence of multidrug resistance reinforces the need for the discovery of novel antibiotics. This is particularly true for tuberculosis (TB) for which 3.7% of new cases and 20% of previously treated cases are estimated to be caused by multi-drug resistant strains. In addition, in the case of TB, which claimed 1.5 million lives in 2014, the treatment of the least complicated, drug sensitive cases is lengthy and disagreeable. Therefore, new drugs with novel targets are urgently needed to control resistant Mycobacterium tuberculosis strains. In this manuscript we report the characterization of the thiopeptide micrococcin P1 as an anti-tubercular agent. Our biochemical experiments show that this antibiotic inhibits the elongation step of protein synthesis in mycobacteria. We have further identified micrococcin resistant mutations in the ribosomal protein L11 (RplK); the mutations were located in the proline loop at the N-terminus. Reintroduction of the mutations into a clean genetic background, confirmed that they conferred resistance, while introduction of the wild type RplK allele into resistant strains re-established sensitivity. We also identified a mutation in the 23S rRNA gene. These data, in good agreement with previous structural studies suggest that also in M. tuberculosis micrococcin P1 functions by binding to the cleft between the 23S rRNA and the L11 protein loop, thus interfering with the binding of elongation factors Tu and G (EF-Tu and EF-G) and inhibiting protein translocation.
We also recommend Trading Suppliers and Manufacturers of micrococcin (cas 1392-45-6). Pls Click Website Link as below: cas 1392-45-6 suppliers
Prev:micrococcin (cas 1392-45-6) P1, a naturally occurring macrocyclic peptide inhibiting hepatitis C virus entry in a pan-genotypic manner
Next:The constitution of micrococcin (cas 1392-45-6) P1: the Bycroft–Gowland hypothesis confirmed) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- ArticleTranslational Regulation via L11: Molecular Switches on the Ribosome Turned On and Off by Thiostrepton and micrococcin (cas 1392-45-6)09/07/2019
- Initiation Factor IF2, Thiostrepton and micrococcin (cas 1392-45-6) Prevent the Binding of Elongation Factor G to the Escherichia coli Ribosome09/06/2019
- Regular articleThe antibiotic micrococcin (cas 1392-45-6) acts on protein L11 at the ribosomal GTPase centre109/05/2019
- Optimization of culture conditions and medium composition for the production of micrococcin (cas 1392-45-6) GO5 by Micrococcus sp. GO509/04/2019
- The constitution of micrococcin (cas 1392-45-6) P1: the Bycroft–Gowland hypothesis confirmed09/03/2019
- micrococcin (cas 1392-45-6) P1, a naturally occurring macrocyclic peptide inhibiting hepatitis C virus entry in a pan-genotypic manner09/01/2019


